|
|
|
| Webinar: The mRNA Journey: From Design to LNP-Ready Molecules for Research | Discover an optimized end-to-end workflow for producing high-quality IVT mRNA for research applications. This Agilent webinar covers every step—from sequence design and PCR-based DNA template preparation to transcription, lipid nanoparticle formulation, and QC testing with Agilent TapeStation and Fragment Analyzer systems—enabling fast, reliable, small-scale mRNA production for non-clinical research such as vaccines, protein expression, and gene or cell therapy. Watch it here. |
|
|
|
|
By Victor Lien | Explicitly mapping delivery challenges to the associated GMP process steps converts biological risk into operational risk. | |
|
|
|
By T. Hitchcock, AGH Bioconsulting, and P. Probert, director of biologics & RNA Centre for Excellence, CPI | Personalized cancer vaccines are becoming feasible, but scaling fast, affordable, data-driven manufacturing is the central challenge to bringing these individualized therapies to more patients. | |
|
|
|
In this Advancing RNA Live clip, Khaled Yamout and Sanofi’s Francoise Ribes share the quality considerations that are top of mind when evaluating a novel raw material, as well as how the broader industry (i.e., standard setting organizations, suppliers, and biotechs) can arrive at a clearer understanding of a material’s quality. |
|
|
|
| ESMO Congress 2025: Highlights From Berlin | Article | By Beata Zukowska, Novotech | Turn the insights from 2025’s ESMO into action by partnering to accelerate innovation through smarter trial design, stronger biomarker planning, and truly global collaboration. |
|
|
| Analyzing Poly(A) Tails Of In Vitro Transcribed RNA | Application Note | By Lisa Houston and Whitney Pike, Agilent Technologies | Find out how to achieve reliable IVT mRNA quality. Learn the best practices for precise analysis, including proper sample prep and system optimization for high-resolution results. |
|
|
|
|
| Screening T7 Polymerases To Optimize xRNA Yield And Quality | Article | By Jing Zhu, Ph.D., Recipharm Advanced Bio | Understand how the evolution of T7 polymerase is optimizing in vitro transcription for RNA therapeutics, and how to balance performance, cost, and supply to make smart choices for your xRNA manufacturing. |
|
|
|
|
|
|
| BioPlan Associates is conducting its 23rd Annual Global Biopharmaceutical Manufacturing and Trends Analysis and needs your insights for the biopharma industry’s most comprehensive global benchmarking analysis! For over 20 years, BioPlan Associates has analyzed advances in bioprocessing, new technologies, and emerging trends, supported by global institutional and media partners. For all completed, qualified surveys, they'll offer an Amazon e-gift card, a copy of the summary results, and the 2026 Top Trends in Biomanufacturing White Paper. |
|
|
|
|
|
|
|
.png){kind=logo}
